Which stock is cheaper: DRREDDY or CIPLA?

Based on Price to Earnings, DRREDDY trades at a P/E of 30.5 while CIPLA trades at a P/E of 32.3.

Does DRREDDY or CIPLA have higher ROCE?

DRREDDY generates an ROCE of 10.4% compared to CIPLA's ROCE of 15.9%.

DR. REDDY S LABORATORIES (DRREDDY) has a market cap of ₹97,085 Cr compared to CIPLA LTD (CIPLA) with ₹1,10,353 Cr.

DRREDDYHealthcare

₹1,352.00+0.52%

Market Cap: ₹97,085 Cr

CIPLAHealthcare

Leads (4/5)

₹1,378.90+1.54%

Market Cap: ₹1,10,353 Cr

Automated quantitative breakdown of fundamental strengths between DRREDDY and CIPLA.

Attractive ValuationDRREDDY (P/E 30.5)Trades at lower Price-to-Earnings

Capital EfficiencyCIPLA (ROCE 15.9%)Superior operating return on capital

Balance Sheet SafetyCIPLALower debt-to-equity ratio

Shareholder YieldCIPLA (6.82%)Higher annual dividend yield

Green highlight indicates the stronger metric

Financial Metric	DRREDDY	CIPLA
Valuation Multiples
Market Capitalization	₹97,085 Cr	₹1,10,353 Cr
Price to Earnings (P/E)	30.49	32.32
Price to Book (P/B)	2.72	3.23
Profitability & Capital Efficiency
Return on Capital Employed (ROCE)	10.39%	15.89%
Return on Equity (ROE)	21.61%	11.12%
Operating Profit Margin (OPM)	13.42%	16.22%
Net Profit Margin (NPM)	2.94%	23.17%
Balance Sheet & Solvency
Debt to Equity Ratio	0.22	0.00
Dividend Yield	4.73%	6.82%
Historical Growth
3-Year Sales Growth (CAGR)	-18.49%	1.84%
Latest Quarter Financial Results
Quarterly Revenue (30 Jun 2026)	₹8,071 Cr	₹7,077 Cr
Quarterly Net Profit	₹444 Cr	₹789 Cr